Ohmeda's medical equipment service policy targeted in Nov. 1 suit by independent servicers.
This article was originally published in The Gray Sheet
Executive SummaryOHMEDA'S MEDICAL EQUIPMENT SERVICE POLICY TARGETED IN LAWSUIT filed by 13 independent medical equipment service providers on Nov. 1. The suit, filed in the U.S. District Court in Sacramento, California, accuses Ohmeda of antitrust violations stemming from its alleged refusal to make spare parts, equipment repair training, and component repair services available to independent service organizations (ISOs) which compete with Ohmeda to provide maintenance of Ohmeda medical equipment. The plaintiffs are seeking injunctive relief, treble damages, costs and attorney's fees.
You may also be interested in...
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.
We clean out your Martin Luther King Day inbox so you don't have to.
Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.